Neogen Corp (NEOG) stock
Close on Nov 17, 2026Market cap $2.38BP/E –Yield –
Earnings
Neogen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Neogen's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Nov 30, 2026 | Jan 7, 2027Expected | – | – | – | – | – |
| Q1 FY2027ended Aug 31, 2026 | Oct 6, 2026after the close | $222.80M | +6.5% | -$0.05 | $0.08 | Release |
| Q4 FY2026ended May 31, 2026 | Jul 30, 2026before the open | $225.30M | -0.1% | -$0.05 | $0.09 | Release |
| Q3 FY2026ended Feb 28, 2026 | Apr 9, 2026before the open | $211.20M | -4.4% | -$0.08 | $0.09 | Release |
| Q2 FY2026ended Nov 30, 2025 | Jan 8, 2026before the open | $224.70M | -2.9% | -$0.07 | $0.10 | Release |
| Q1 FY2026ended Aug 31, 2025 | Oct 9, 2025before the open | $209.20M | -3.6% | $0.17 | $0.04 | Release |
| Q4 FY2025ended May 31, 2025 | Jul 29, 2025before the open | $225.50M | -4.8% | -$2.82 | $0.05 | Release |
| Q3 FY2025ended Feb 28, 2025 | Apr 9, 2025before the open | $221.00M | -3.4% | -$0.05 | $0.10 | Release |
| Q2 FY2025ended Nov 30, 2024 | Jan 10, 2025before the open | $231.30M | +0.7% | -$2.10 | $0.11 | Release |
| Q1 FY2025ended Aug 31, 2024 | Oct 10, 2024before the open | $217.00M | -5.2% | -$0.06 | $0.07 | Release |
| Q4 FY2024ended May 31, 2024 | Jul 30, 2024before the open | $236.80M | -2.1% | -$0.02 | $0.10 | Release |
| Q3 FY2024ended Feb 29, 2024 | Apr 9, 2024before the open | $228.80M | +4.8% | -$0.01 | $0.12 | Release |
| Q2 FY2024ended Nov 30, 2023 | Jan 9, 2024before the open | $229.60M | -0.2% | -$0.02 | $0.11 | Release |
| Q1 FY2024ended Aug 31, 2023 | Oct 10, 2023during market hours | $229.00M | +73.0% | $0.01 | $0.11 | Release |
| Q4 FY2023ended May 31, 2023 | Jul 27, 2023before the open | $241.80M | +72.6% | $0.03 | $0.14 | Release |
| Q3 FY2023ended Feb 28, 2023 | Mar 30, 2023before the open | $218.30M | +70.2% | $0.04 | $0.12 | Release |
| Q2 FY2023ended Nov 30, 2022 | Jan 5, 2023after the close | $230.00M | +76.2% | -$0.19 | $0.15 | Release |
| Q1 FY2023ended Aug 31, 2022 | Sep 28, 2022during market hours | $132.35M | – | $0.05 | $0.15 | Release |
| Q4 FY2022ended May 31, 2022 | Jul 27, 2022after the close | $140.09M | – | $0.14 | $0.18 | Release |
| Q3 FY2022ended Feb 28, 2022 | Mar 24, 2022after the close | $128.24M | – | $0.05 | $0.13 | Release |
| Q2 FY2022ended Nov 30, 2021 | Dec 22, 2021during market hours | $130.52M | – | $0.10 | $0.17 | Release |
| Q1 FY2022ended Aug 31, 2021 | Sep 22, 2021after the close | – | – | – | – | Filing |
| Q4 FY2021ended May 31, 2021 | Jul 21, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2021ended Feb 28, 2021 | Mar 23, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Nov 30, 2020 | Dec 22, 2020during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Aug 31, 2020 | Sep 23, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Neogen's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| total revenue | FY2027 | $885.00M – $890.00M | $880.00M – $885.00M | Raised | Oct 6, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $181.00M – $183.00M | $180.00M – $182.00M | Raised | Oct 6, 2026 |
Guidance vs results
The last range Neogen gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q1 FY2027 | Revenue | $207.00M – $209.00M | $222.80M | Above range |
| FY2026 | Revenue | $857.00M – $860.00M | $870.40MΣ4Q | Above range |
| FY2025 | Revenue | $895.00M | $894.80MΣ4Q | Within range |
Guidance history
Every forecast Neogen put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 6, 2026 | Adjusted EBITDA | FY2027 | $181.00M – $183.00M | Raised |
| Oct 6, 2026 | total revenue | FY2027 | $885.00M – $890.00M | Raised |
| Jul 30, 2026 | adjusted EBITDA | FY2027 | $180.00M – $182.00M | New |
| Jul 30, 2026 | Adjusted EBITDA | Q1 FY2027 | $37.00M | New |
| Jul 30, 2026 | total revenue | FY2027 | $880.00M – $885.00M | New |
| Jul 30, 2026 | total revenue | Q1 FY2027 | $207.00M – $209.00M | New |
| Apr 9, 2026 | adjusted EBITDA | FY2026 | $175.00M | Reaffirmed |
| Apr 9, 2026 | revenue | FY2026 | $857.00M – $860.00M | Raised |
| Jan 8, 2026 | Capital expenditures | FY2026 | $50.00M | Reaffirmed |
| Jan 8, 2026 | Adjusted EBITDA | FY2026 | $175.00M | Raised |
| Jan 8, 2026 | Revenue | FY2026 | $845.00M – $855.00M | Raised |
| Oct 9, 2025 | Capital expenditures | FY2026 | $50.00M | Reaffirmed |
| Oct 9, 2025 | Adjusted EBITDA | FY2026 | $165.00M – $175.00M | Reaffirmed |
| Oct 9, 2025 | Revenue | FY2026 | $820.00M – $840.00M | Reaffirmed |
| Jul 29, 2025 | Capital expenditures | FY2026 | $50.00M | New |
| Jul 29, 2025 | Adjusted EBITDA | FY2026 | $165.00M – $175.00M | New |
| Jul 29, 2025 | Revenue | FY2026 | $820.00M – $840.00M | New |
| Apr 9, 2025 | capital expenditures | FY2025 | $100.00M | New |
| Apr 9, 2025 | Adjusted EBITDA | FY2025 | $195.00M | New |
| Apr 9, 2025 | Revenue | FY2025 | $895.00M | New |
| Jan 10, 2025 | capital expenditures | FY2025 | $85.00M | New |
| Jan 10, 2025 | Adjusted EBITDA | FY2025 | $205.00M – $215.00M | Lowered |
| Jan 10, 2025 | revenue | FY2025 | $905.00M – $925.00M | New |
| Oct 10, 2024 | capital expenditures | FY2025 | $85.00M | Reaffirmed |
| Oct 10, 2024 | Adjusted EBITDA | FY2025 | $215.00M – $235.00M | Reaffirmed |
| Oct 10, 2024 | Revenue | FY2025 | $925.00M – $955.00M | Reaffirmed |
| Jul 30, 2024 | capital expenditures | FY2025 | $85.00M | New |
| Jul 30, 2024 | Adjusted EBITDA | FY2025 | $215.00M – $235.00M | New |
| Jul 30, 2024 | Revenue | FY2025 | $925.00M – $955.00M | New |
| Apr 9, 2024 | capital expenditures | FY2024 | $130.00M | Reaffirmed |
| Apr 9, 2024 | Adjusted EBITDA | FY2024 | $210.00M – $215.00M | Lowered |
| Apr 9, 2024 | Revenue | FY2024 | $910.00M – $920.00M | Lowered |
| Jan 9, 2024 | capital expenditures | FY2024 | $130.00M | Reaffirmed |
| Jan 9, 2024 | Adjusted EBITDA | FY2024 | $230.00M – $240.00M | Lowered |
| Jan 9, 2024 | revenue | FY2024 | $935.00M – $955.00M | Lowered |
| Oct 10, 2023 | capital expenditures | FY2024 | $130.00M | New |
| Oct 10, 2023 | Adjusted EBITDA | FY2024 | $235.00M – $255.00M | Reaffirmed |
| Oct 10, 2023 | revenue | FY2024 | $955.00M – $985.00M | New |
| Jul 27, 2023 | capital expenditures | FY2024 | $130.00M | New |
| Jul 27, 2023 | Adjusted EBITDA | FY2024 | $235.00M – $255.00M | New |
| Jul 27, 2023 | total revenue | FY2024 | $955.00M – $985.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Neogen filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- Results
- News
- News
- News
- Results
- Update
- Update
- Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. TobinNews
- Update
- Results
See a number that looks wrong?